CIK 0001534248 · Non-accelerated filer<br>Smaller reporting company
Chemomab Therapeutics Ltd.
Sign in to watch- Ticker
- CMMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- EIN
- 813676773
- Phone
- 972-77-331-0156
- Business address
- KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
- Former names
- Anchiano Therapeutics Ltd., BioCancell Ltd.
- 6-K Event Report of Foreign Issuer
- 424B5 Offering Prospectus
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- SC 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- F-3 Offering F-3
- 6-K Event Report of Foreign Issuer
- SC 13G Stake Amended Statement of Ownership
- D Other Notice of Sales of Unregistered Securities
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 20-F Report Annual and Transition Report of Foreign Private Issuers
Page 4 of 19 · 368 filings